Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

BMS to comarket antiemetic azasetron in Japan

June 27, 1997

NDA for entacapone scheduled for submission this month

June 27, 1997

Preclinical profile of MDL-27192

June 27, 1997

SKB discovers first selective human 5-HT1B receptor ligand

June 27, 1997

Novel anxiolytic and antidepressant buspirone analogue characterized

June 27, 1997

MS&D reports another series of potent and selective 5-HT1D agonists

June 27, 1997

NMDA antagonists improve memory deficits after brain injury in the rat

June 26, 1997

Univ. of Tokyo scientists isolate potent and selective papain inhibitor

June 26, 1997

Efficacy of SB-206284A in animal models of cerebral ischemia

June 26, 1997

MS&D prepares potent and selective 5-HT1D agonists

June 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...